Depression in Parkinson's disease - Part 1: Epidemiology, signs and symptoms, pathophysiology and diagnosis;Depression beim idiopathischen Parkinson-syndrom - Teil 1: Epidemiologie, pathophysiologie, klinik und diagnostik

Fortschritte der Neurologie Psychiatrie

Volumn 76, Issue 12, 2008, Pages 715-724

  Storch, Alexander ^a   Ebersbach, G ^b   Fuchs, G ^c   Jost, W H ^d   Odin, P ^e   Reifschneider, C ^f   Bauer, M ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Kliniken Beelitz GmbH Neurologisches Fachkrankenhaus für Bewegungsstörungen Parkinson   (Germany)

^c Neurologisches Krankenhaus   (Germany)

^d DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^e Klinikum Bremerhaven Reinkenheide   (Germany)

^f Neuro Centrum Odenwald   (Germany)

Author keywords

Depression; Diagnosis; Epidemiology; Parkinson's disease; Pathophysiology; Scales

Indexed keywords

APATHY; AUTONOMIC DYSFUNCTION; COMORBIDITY; DEMENTIA; DEPRESSION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISABILITY; DISEASE COURSE; HUMAN; NEUROPSYCHIATRY; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; QUALITY OF LIFE; REVIEW;

EID: 58149402561     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1038293     Document Type: Review

References (79)

1. Schräg A. Quality of life and depression in Parkinson's disease. Journal of the neurological sciences 2006; 248: 151-157
2. Weintraub D, Moberg PJ, Duda JE et al. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. Journal of the American Geriatrics Society 2004; 52: 784-788
3. Shulman LM, Taback RL, Rabinstein AA et al. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002; 8: 193-197
4. Weintraub D, Moberg PJ, Duda JE et al. Recognition and treatment of depression in Parkinson's disease. Journal of geriatric psychiatry and neurology 2003; 16: 178-183
5. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet neurology 2006; 5: 235-245
6. Veazey C, Aki SO, Cook KF et al. Prevalence and treatment of depression in Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences 2005; 17: 310-323
7. Taylor AE, Saint-Cyr JA, Lang AE et al. Parkinson's disease and depression. A critical re-evaluation. Brain 1986; 109 (Pt 2): 279-292
8. Nilsson FM, Kessing LV, Sorensen TM et al. Major depressive disorder in Parkinson's disease: a register-based study. Acta psychiatrica Scandinavica 2002; 106: 202-211
9. Mayeux R, Stern Y, Rosen J et al. Depression, intellectual impairment, and Parkinson disease. Neurology 1981; 31: 645-650
10. Ehmann TS, Beninger RJ, Gawel MJ et al. Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects. Journal of geriatric psychiatry and neurology 1990; 3: 3-9
11. Slaughter JR, Slaughter KA, Nichols D et al. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences 2001; 13: 187-196
12. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson's disease. Biological psychiatry 2003; 54: 363-375
13. Leentjens AF. Depression in Parkinson's disease: conceptual issues and clinical challenges. Journal of geriatric psychiatry and neurology 2004; 17: 120-126
14. Hughes AJ, Daniel SE, Blankson S et al. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140-148
15. Hughes AJ, Daniel SE, Kilford L et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184
16. Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression screening scale: a preliminary report. Journal of psychiatric research 1982; 17: 37-49
17. Ravina B, Camicioli R, Como PG et al. The impact of depressive symptoms in early Parkinson disease. Neurology 2007; 69: 342-347
18. Barone P, Groot AA, Goetz CG et al. Depression and antidepression use in Parkinson's disease: results from the PRODEST-PD study. Brussels: 11th Congress of the European Federation of Neurological Societies (EFNS), 25-28 Aug 2007
19. Pedersen KF, Larsen JP, Alves G et al. Prevalence and clinical correlates of apathy in Parkinson's disease: A community-based study. Parkinsonism Relat Disord 2008
20. Dujardin K, Sockeet P, Devos D et al. Characteristics of apathy in Parkinson's disease. Mov Disord 2007; 22: 778-784
21. Aarsland D, Larsen JP, Lim NG et al. Range of neuropsychiatrie disturbances in patients with Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry 1999; 67: 492-496
22. Starkstein SE, Mayberg HS, Preziosi TJ et al. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences 1992; 4: 134-139
23. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? Journal of neurology, neurosurgery, and psychiatry 2000; 69: 308-312
24. Kuopio AM, Marttila RJ, Helenius H et al. The quality of life in Parkinson's disease. Mov Disord 2000; 15: 216-223
25. Kuhn W, Heye N, Muller T et al. The motor performance test series in Parkinson's disease is influenced by depression. J Neural Transm 1996; 103: 349-354
26. Brown R, Jahanshahi M. Depression in Parkinson's disease: a psychosocial viewpoint. Advances in neurology 1995; 65: 61-84
27. Cummings JL, Masterman DL. Depression in patients with Parkinson's disease. International journal of geriatric psychiatry 1999; 14: 711-718
28. Santamaria J, Tolosa E, Valles A. Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 1986; 36: 1130-1133
29. Shiba M, Bower JH, Maraganore DM et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000; 15: 669-677
30. Brown RG, MacCarthy B, Gotham AM et al. Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychological medicine 1988; 18: 49-55
31. Lemke MR, Fuchs G, Gemende I et al. Depression and Parkinson's disease. J Neurol 2004; 251 Suppl 6: VI/24-27
32. Marder K, Tang MX, Cote L et al. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Archives of neurology 1995; 52: 695-701
33. Starkstein SE, Petracca G, Chemerinski E et al. Depression in classic versus akinetic-rigid Parkinson's disease. Mov Disord 1998; 13: 29-33
34. Giladi N, Treves TA, Paleacu D et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm 2000; 107: 59-71
35. Derix MMA, Gilhuis HJ, Hoogendijk WJ. Depressive syndrome in Parkinson' disease: diagnostic pitfalls. In: Wolters EC, Scheltens P (eds). Mental dysfunction in Parkinson's disease. Amsterdam: Krijek University Press, 1993: 335-353
36. Cummings JL. Depression and Parkinson's disease: a review. The American journal of psychiatry 1992; 149: 443-454
37. Poewe W, Luginger E. Depression in Parkinson's disease: impediments to recognition and treatment options. Neurology 1999; 52: S2-6
38. Judd LL, Rapaport MH, Paulus MP et al. Subsyndromal symptomatic depression: a new mood disorder? The Journal of clinical psychiatry 1994; 55 Suppl: 18-28
39. Maricle RA, Nutt JG, Carter JH. Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings. Mov Disord 1995; 10: 329-332
40. Richard IH, Justus AW, Kurlan R. Relationship between mood and motor fluctuations in Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences 2001; 13: 35-41
41. Marsh L, McDonald WM, Cummings J et al. Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord 2006; 21: 148-158
42. Dujardin K, Sockeel P, Delliaux M et al. The Lille Apathy Rating Scale: validation of a caregiver-based version. Mov Disord 2008; 23: 845-849
43. Lauterbach EC, Freeman A, Vogel RL. Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences 2004; 16: 29-36
44. Nilsson FM, Kessing LV, Bolwig TG. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta psychiatrica Scandinavica 2001; 104: 380-386
45. Schuurman AG, Akker M van den, Ensinck KT et al. Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology 2002; 58: 1501-1504
46. Angst J, Preisig M. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr 1995; 146: 5-16
47. Angst J, Preisig M. Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr 1995; 146: 17-23
48. Remy P, Doder M, Lees A et al. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005; 128: 1314-1322
49. Mann JJ. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 1999; 21: 99S-105S
50. Sargent PA, Kjaer KH, Bench CJ et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]-WAY-100635: effects of depression and antidepressant treatment. Archives of general psychiatry 2000; 57: 174-180
51. Meyer JH, Kapur S, Eisfeld B et al. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F[setoperone PET imaging study. The American journal of psychiatry 2001; 158: 78-85
52. Meyer JH, Kapur S, Houle S et al. Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. The American journal of psychiatry 1999; 156: 1029-1034
53. Messa C, Colombo C, Moresco RM et al. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology 2003; 167: 72-78
54. Zanardi R, Artigas F, Moresco R et al. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. Journal of clinical psychopharmacology 2001; 21: 53-58
55. Meyer JH. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci 2007; 32: 86-102
56. Meyer JH, Houle S, Sagrati S et al. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Archives of general psychiatry 2004; 61: 1271-1279
57. Mann JJ, Huang YY, Underwood MD et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Archives of general psychiatry 2000; 57: 729-738
58. Mann JJ, Malone KM. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biological psychiatry 1997; 41: 162-171
59. Brooks DJ, Piccini P. Imaging in Parkinson's disease: the role of monoamines in behavior. Biological psychiatry 2006; 59: 908-918
60. Kim SE, Choi JY, Choe YS et al. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT. J Nucl Med 2003; 44: 870-876
61. O'Suilleabhain PE, Sung V, Hernandez C et al. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations. Archives of neurology 2004; 61: 865-868
62. Hoogendijk WJ, Sommer IE, Tissingh G et al. Depression in Parkinson's disease. The impact of symptom overlap on prevalence. Psychosomatics 1998; 39: 416-421
63. Koenig HG, George LK, Peterson BL et al. Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. The American journal of psychiatry 1997; 154: 1376-1383
64. McDowell I, Newel C. Measuring health. A guide to rating scales and questionaires. 2nd ed. Oxford: Oxford University Press, 1996
65. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. British medical journal Clinical research ed 1986; 292: 344
66. Mondolo F, Jahanshahi M, Grana A et al. The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson's disease. Behavioural neurology 2006; 17: 109-115
67. Hamilton M. Development of a rating scale for primary depressive illness. The British journal of social and clinical psychology 1967; 6: 278-296
68. Dissanayaka NN, Sellbach A, Matheson S et al. Validity of Hamilton Depression Inventory in Parkinson's disease. Mov Disord 2007; 22: 399-403
69. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389
70. Fahn S, Elton RL, Committee UD. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB (eds). Recent developments in Parkinson's disease. Florham Park: Macmillan Healthcare Information, 1987: 153-163, 293-304
71. Schrag A, Barone P, Brown RG et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007; 22: 1077-1092
72. Kuhner C, Burger C, Keller F et al. Reliability and validity of the Revised Beck Depression Inventory (BDI-Il). Results from German samples. Der Nervenarzt 2007; 78: 651-656
73. Sockeel P, Dujardin K, Devos D et al. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry 2006; 77: 579-584
74. Robert PH, Clairet S, Benoit M et al. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. International journal of geriatric psychiatry 2002; 17: 1099-1105
75. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry research 1991; 38: 143-162
76. Pedersen KF, Larsen JP, Aarsland D. Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease. Parkinsonism Relat Disord 2008; 14: 183-186
77. Primack BA. The WHO-5 Wellbeing Index performed the best in screening for depression in primary care. ACP journal club 2003; 139: 48
78. Mergl R, Seidscheck I, Allgaier AK et al. Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition. Depression and anxiety 2007; 24: 185-195
79. Brand S, Dodel R, Hautzinger M et al. (Depression in Parkinson's disease. Assessment and treatment]. Der Nervenarzt 2007; 78: 715-727; quiz 728